816 related articles for article (PubMed ID: 31078242)
1. The Microbiota and the Immune Response: What Is the Chicken and What Is the Egg?
Fritsch J; Abreu MT
Gastrointest Endosc Clin N Am; 2019 Jul; 29(3):381-393. PubMed ID: 31078242
[TBL] [Abstract][Full Text] [Related]
2. Links Between Inflammatory Bowel Disease and Chronic Obstructive Pulmonary Disease.
Raftery AL; Tsantikos E; Harris NL; Hibbs ML
Front Immunol; 2020; 11():2144. PubMed ID: 33042125
[TBL] [Abstract][Full Text] [Related]
3. Manipulating resident microbiota to enhance regulatory immune function to treat inflammatory bowel diseases.
Mishima Y; Sartor RB
J Gastroenterol; 2020 Jan; 55(1):4-14. PubMed ID: 31482438
[TBL] [Abstract][Full Text] [Related]
4. Inflammatory Bowel Diseases (IBD) and the Microbiome-Searching the Crime Scene for Clues.
Lee M; Chang EB
Gastroenterology; 2021 Jan; 160(2):524-537. PubMed ID: 33253681
[TBL] [Abstract][Full Text] [Related]
5. Microbiota dysbiosis and barrier dysfunction in inflammatory bowel disease and colorectal cancers: exploring a common ground hypothesis.
Yu LC
J Biomed Sci; 2018 Nov; 25(1):79. PubMed ID: 30413188
[TBL] [Abstract][Full Text] [Related]
6. Mechanisms of Pediatric Inflammatory Bowel Disease.
Peloquin JM; Goel G; Villablanca EJ; Xavier RJ
Annu Rev Immunol; 2016 May; 34():31-64. PubMed ID: 27168239
[TBL] [Abstract][Full Text] [Related]
7. The Roles of Inflammation, Nutrient Availability and the Commensal Microbiota in Enteric Pathogen Infection.
Stecher B
Microbiol Spectr; 2015 Jun; 3(3):. PubMed ID: 26185088
[TBL] [Abstract][Full Text] [Related]
8. Microbiome and colorectal cancer: Unraveling host-microbiota interactions in colitis-associated colorectal cancer development.
Kang M; Martin A
Semin Immunol; 2017 Aug; 32():3-13. PubMed ID: 28465070
[TBL] [Abstract][Full Text] [Related]
9. Gut microbiota in the pathogenesis of inflammatory bowel disease.
Nishida A; Inoue R; Inatomi O; Bamba S; Naito Y; Andoh A
Clin J Gastroenterol; 2018 Feb; 11(1):1-10. PubMed ID: 29285689
[TBL] [Abstract][Full Text] [Related]
10. Gut microbiota and IBD: causation or correlation?
Ni J; Wu GD; Albenberg L; Tomov VT
Nat Rev Gastroenterol Hepatol; 2017 Oct; 14(10):573-584. PubMed ID: 28743984
[TBL] [Abstract][Full Text] [Related]
11. Gut microbiome in primary sclerosing cholangitis: A review.
Little R; Wine E; Kamath BM; Griffiths AM; Ricciuto A
World J Gastroenterol; 2020 Jun; 26(21):2768-2780. PubMed ID: 32550753
[TBL] [Abstract][Full Text] [Related]
12. Interrelatedness between dysbiosis in the gut microbiota due to immunodeficiency and disease penetrance of colitis.
Ray A; Dittel BN
Immunology; 2015 Nov; 146(3):359-68. PubMed ID: 26211540
[TBL] [Abstract][Full Text] [Related]
13. The intestinal microbiota in the pathogenesis of inflammatory bowel diseases: new insights into complex disease.
Harris KG; Chang EB
Clin Sci (Lond); 2018 Sep; 132(18):2013-2028. PubMed ID: 30232239
[TBL] [Abstract][Full Text] [Related]
14. The interplay between microbes and the immune response in inflammatory bowel disease.
Goethel A; Croitoru K; Philpott DJ
J Physiol; 2018 Sep; 596(17):3869-3882. PubMed ID: 29806140
[TBL] [Abstract][Full Text] [Related]
15. Enteroendocrine Cells: Sensing Gut Microbiota and Regulating Inflammatory Bowel Diseases.
Yu Y; Yang W; Li Y; Cong Y
Inflamm Bowel Dis; 2020 Jan; 26(1):11-20. PubMed ID: 31560044
[TBL] [Abstract][Full Text] [Related]
16. Microbial Signatures and Innate Immune Gene Expression in Lamina Propria Phagocytes of Inflammatory Bowel Disease Patients.
Dheer R; Davies JM; Quintero MA; Damas OM; Deshpande AR; Kerman DH; Sawyer WP; Pignac-Kobinger J; Ban Y; Fernandez I; Burgueno JF; Phillips MC; Abreu MT
Cell Mol Gastroenterol Hepatol; 2020; 9(3):387-402. PubMed ID: 31740421
[TBL] [Abstract][Full Text] [Related]
17. [Intestinal immune response is regulated by gut microbe].
Tanemoto S; Sujino T; Kanai T
Nihon Rinsho Meneki Gakkai Kaishi; 2017; 40(6):408-415. PubMed ID: 29367525
[TBL] [Abstract][Full Text] [Related]
18. Dynamics of the human gut microbiome in inflammatory bowel disease.
Halfvarson J; Brislawn CJ; Lamendella R; Vázquez-Baeza Y; Walters WA; Bramer LM; D'Amato M; Bonfiglio F; McDonald D; Gonzalez A; McClure EE; Dunklebarger MF; Knight R; Jansson JK
Nat Microbiol; 2017 Feb; 2():17004. PubMed ID: 28191884
[TBL] [Abstract][Full Text] [Related]
19. Dismicrobism in inflammatory bowel disease and colorectal cancer: changes in response of colocytes.
Tomasello G; Tralongo P; Damiani P; Sinagra E; Di Trapani B; Zeenny MN; Hussein IH; Jurjus A; Leone A
World J Gastroenterol; 2014 Dec; 20(48):18121-30. PubMed ID: 25561781
[TBL] [Abstract][Full Text] [Related]
20. Interplay of host genetics and gut microbiota underlying the onset and clinical presentation of inflammatory bowel disease.
Imhann F; Vich Vila A; Bonder MJ; Fu J; Gevers D; Visschedijk MC; Spekhorst LM; Alberts R; Franke L; van Dullemen HM; Ter Steege RWF; Huttenhower C; Dijkstra G; Xavier RJ; Festen EAM; Wijmenga C; Zhernakova A; Weersma RK
Gut; 2018 Jan; 67(1):108-119. PubMed ID: 27802154
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]